Seoul Pharma Co. Ltd Cash Flow Reinvestment Rate
Seoul Pharma Co. Ltd cash flow reinvestment rate. Seoul Pharma Co. Ltd (018680) has a Cash Flow Reinvestment Rate of 0.52x as of June 2025, reinvesting ₩1.07 Billion (capex ₩89.75 Million plus investments ₩979.26 Million) from operating cash flow of ₩2.07 Billion. Explore Seoul Pharma Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Seoul Pharma Co. Ltd (2009–2023)
Cash flow reinvestment rate of Seoul Pharma Co. Ltd from 2009 to 2023. Historical reinvestment intensity for Seoul Pharma Co. Ltd across 8 annual periods. Explore 018680 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Seoul Pharma Co. Ltd Cash Flow Reinvestment Rate by Year (2009–2023)
Seoul Pharma Co. Ltd cash flow reinvestment rate by year from 2009 to 2023. Year-by-year capital reinvestment analysis for Seoul Pharma Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of Seoul Pharma Co. Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.47x | ₩7.76 Billion | ₩5.26 Billion | ₩1.89 Billion | ▲ +776.4% |
| 2020 | 0.17x | ₩964.40 Million | ₩5.74 Billion | ₩671.25 Million | ▲ +214.7% |
| 2019 | 0.05x | ₩156.43 Million | ₩2.93 Billion | ₩156.43 Million | ▼ -94.7% |
| 2015 | 1.01x | ₩1.43 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -43.8% |
| 2014 | 1.80x | ₩2.66 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -7.8% |
| 2012 | 1.95x | ₩17.95 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +71.3% |
| 2011 | 1.14x | ₩5.53 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -78.8% |
| 2009 | 5.36x | ₩6.62 Billion | ₩1.23 Billion | ₩6.11 Billion | — |